A review of the spectrum of antisense technologies reveals that considerable progress has been made during the past decade. This is more than in any other biopharmaceutical segment.
This report discusses the key antisense technologies, which have an impact on drug discovery and molecular diagnostics. Prominent among these are antisense gene therapy, ribozymes, triple helix forming oligonucleotides and peptide nucleic acid (PNA).
